🔴 Do #SGLT2i have a role in #CardioOnc ? This review article highlights the cardioprotective evidence and the anticancer potential of SGLT2i in cardio-oncology. bit.ly/4ccqRCd

#JACCCardioOnc #CardioEd #CardioTwitter #cardiology

Cardiac atrophy, myocardial hypometabolism, mitophagy, and nutrient sensing emerge in a mouse model as novel therapeutic targets to prevent anthracycline-induced #cardiotoxicity bit.ly/3whP5uM

#JACCCardioOnc #CardioOnc #HeartFailure #Anthracycline

Masterful talks #CardioOnc day 2 MSK CME MSK Department of Medicine #MSKCardioOncCME

Take aways from SUCCOUR and how to use biomarkers in #cardioonc from the GLS and biomarker guru! dineshpmcc #MSKCardioOncCME MSK CME Memorial Sloan Kettering Cancer Center #echofirst

#cardioonc expert extraordinaire Ana Barac, MD, PhD, FACC, FAHA walking us through the latest in CardioOncology research and evidence based cardioprotection #MSKCardioOncCME MSK CME Memorial Sloan Kettering Cancer Center

Excited to increase awareness about the field of #CardioOnc and our program at NewYork-Presbyterian Weill Cornell Medicine with the help of the awesome team at Advances in Care
nyp.org/advances/podca…

#CardioOnc Jayant Raikhelkar #MSKCardioOncCME Memorial Sloan Kettering Cancer Center MSK CME

Day 2 immersive #Cardioonc #MSKCardioOncCME MSK CME Memorial Sloan Kettering Cancer Center
Science and collaboration

Nice to be spending the day ACC Liverpool at the BSH - Haematology conference learning from and with #haemoncologists ! Andrew J Wilson 🇪🇺🏳️‍🌈 BCOS British Cardiovascular Society #cardioonc #cardioonc ology

#MSKCardioOncCME is underway! Dr. Michelle Johnson helping us tackle #SDOH and #disparities in #cardioonc care

2022 European Society of Cardiology International Cardio-Oncology Society #CardioOnc guidelines co-chair Teresa López Fdez expertly guiding us through the validity of risk stratification scores and how to improve upon these tools moving forward #MSKCardioOncCME Memorial Sloan Kettering Cancer Center MSK CME

Dr. Sergio Giralt sharing the history of bone marrow transplantation to know where we came from and where we're headed in #cardioonc #MSKCardioOncCME MSK CME Memorial Sloan Kettering Cancer Center

What is next in #CardioOnc ? Absolutely brilliant Teresa López Fdez draws the next steps: validation of European Society of Cardiology International Cardio-Oncology Society risk scores in different cancer types and treatments and risk-based approach. JACC Journals #JACCCardioOnc Jennifer Liu

Great #CardioOnc talk by Stephanie Feldman on ACS in cancer #MSKCardioOncCME

Antiplatelets should be considered even in thrombocytopenic patients but more data are needed!

Expert guidance from Marielle Scherrer on use of multimodality imaging in #cardioonc #MSKCardioOncCME MSK CME Memorial Sloan Kettering Cancer Center #echofirst #whyCMR #yesCCT

Presentations by our CardioOnc Super-star, Ana Barac, MD, PhD, FACC, FAHA at May 2-3
Memorial Sloan Kettering Cancer Center Symposium

· Top studies/trials
· Best Practices in Management
· Prevention in CardioOnc

mskcc.cloud-cme.com/Assets/mskcc/d…

#CVprev #CardioOnc

NEW #CardioOnc broadcast 'Journal Club: 2 May 2024' 💡ow.ly/yWCM50RshgE

In this month’s Journal Club, Prof Joe Carver is joined by Dr Lorna Devkota, MD who will present an insightful article that delves into the critical research of cardio-oncology 📚

#Cardiology International Cardio-Oncology Society

Older patients w/ Hodgkin #lymphoma have high burden of #HeartFailure w/ less #anthracycline use and high 1-yr mortality. Need improved #CardioOnc strategies & better understanding of risk-benefits bit.ly/3Uhu37t

#JACCCardioOnc #lymsm #cvGeri #ACCGeriatric Jenica Upshaw